Lv4
656 积分 2024-10-30 加入
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Resetting autoimmune disease with CAR cell therapies
2个月前
已完结
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
2个月前
已完结
In vivo CAR-T: a paradigm shift in adoptive cell therapy from bench to beside
2个月前
已完结
CAR-T therapy in solid tumors
3个月前
已完结
Current state of CAR-T cell therapies for solid tumors
3个月前
已完结
In vivo CAR engineering for immunotherapy
3个月前
已完结
In vivo CAR T cell engineering: design principles and open questions
3个月前
已完结
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer
1年前
已完结
Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
1年前
已完结
皖公网安备34019202002308
